Advertisement
Screener

Altamira Therapeutics Ltd. (CYTOF) Form 20-F: Annual report of foreign private issuer

Altamira Therapeutics Ltd. Form 20-F: Annual report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2025-04-30: Form 20-F; Period of report 2024-12-31; Description ANNUAL REPORT; Document ea0237996-20f_altamira.htm.
  • 2024-04-10: Form 20-F; Period of report 2023-12-31; Description ANNUAL REPORT; Document ea0201981-20f_altamirather.htm.
  • 2023-05-16: Form 20-F; Period of report 2022-12-31; Description ANNUAL REPORT; Document f20f2022_altamirather.htm.
  • 2022-04-12: Form 20-F; Period of report 2021-12-31; Description ANNUAL REPORT; Document f20f2021_altamirathera.htm.
FiledFormPeriod of reportDescriptionDocument
2025-04-3020-F2024-12-31ANNUAL REPORTea0237996-20f_altamira.htm
2024-04-1020-F2023-12-31ANNUAL REPORTea0201981-20f_altamirather.htm
2023-05-1620-F2022-12-31ANNUAL REPORTf20f2022_altamirather.htm
2022-04-1220-F2021-12-31ANNUAL REPORTf20f2021_altamirathera.htm
2021-03-3120-F2020-12-31ANNUAL REPORTf20f2020_aurismedicalholding.htm
2020-04-1620-F2019-12-31ANNUAL REPORTf20f2019_aurismedical.htm
2019-03-1420-F2018-12-3120-Fears12312018-20xf.htm
2018-03-2220-F2017-12-3120-Fears12312017-20xf.htm
2017-03-1420-F2016-12-31FORM 20-Fdp73891_20f.htm
2016-03-1420-F2015-12-31FORM 20-Fdp64062_20f.htm
2015-03-3120-F2014-12-31FORM 20-Fdp54644_20f.htm